Physician profile
David Y Zhang
NPI 1912906546
$3,108.49
in general payments reported to CMS, 2019-2025
8 companies · $781 in 2025
The $781 reported for 2025 was more than what 88% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2021: $150 · 2023: $865 · 2024: $1,187 · 2025: $781.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,043 · Travel and Lodging: $502 · Education: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,043.27 |
| Travel and Lodging | $501.78 |
| Education | $288.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,198.39 | 2023-2025 | Aveir, Cardiomems, Jot Dx |
| Medtronic, INC. | $338.00 | 2024 | |
| Biotronik INC. | $228.34 | 2025 | |
| Esperion Therapeutics, INC. | $150.00 | 2021 | |
| Hologic Sales and Service, LLC | $125.00 | 2019 | |
| Pfizer INC. | $30.08 | 2023 | |
| Heartflow, INC. | $29.40 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $9.28 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.